Abstract

Abstract Glioblastoma (GBM) has a poor prognosis despite intensive treatments such as surgical resection, radiation, and chemotherapy, thus new therapeutic strategies are urgently needed to improve the outcome. In addition, invasive nature of glioblastoma is one of the reasons for treatment failure, thus regulating glioblastoma invasion is essential to improve the outcome of GBM patients. To develop new treatment strategies, patient derived xenografts (PDXs) are essential tools for preclinical and translational research for glioblastoma because PDXs recapitulated histological features of original patients’ tumors such as invasion. In this study, we aim to comprehensively analyze the mechanism of glioblastoma invasion using PDXs. We have injected GFP-tagged glioblastoma PDXs lines into the right cerebrum of immunodeficient mice and dissected the right and left cerebrum separately when the mice got tumors. We dissociated the brain, sorted tumor cells by flow cytometry, and extracted RNA from tumor cells in right and left cerebrum, respectively. We performed RNA sequencing and analyzed the transcriptome differences between tumor cells from right cerebrum and left cerebrum. We found significant differences in expression of extracellular matrix related proteins, cell motility related proteins, and cell adhesion related proteins between these two. These findings suggest that PDXs will be of use for comprehensively investigating the mechanism of glioblastoma invasion and extracellular matrix related proteins, cell motility related proteins, and cell adhesion related proteins have significant roles of glioblastoma invasion.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call